GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » China National Accord Medicines Corp Ltd (SZSE:000028) » Definitions » Other Long-Term Liabilities

China National Accord Medicines (SZSE:000028) Other Long-Term Liabilities

: ¥803 Mil (As of Dec. 2023)
View and export this data going back to 1993. Start your Free Trial

China National Accord Medicines's other long-term liabilities for the quarter that ended in Dec. 2023 was ¥803 Mil.

China National Accord Medicines's quarterly other long-term liabilities declined from Jun. 2023 (¥844 Mil) to Sep. 2023 (¥828 Mil) and declined from Sep. 2023 (¥828 Mil) to Dec. 2023 (¥803 Mil).

China National Accord Medicines's annual other long-term liabilities declined from Dec. 2021 (¥935 Mil) to Dec. 2022 (¥799 Mil) but then increased from Dec. 2022 (¥799 Mil) to Dec. 2023 (¥803 Mil).


China National Accord Medicines Other Long-Term Liabilities Historical Data

The historical data trend for China National Accord Medicines's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China National Accord Medicines Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Long-Term Liabilities
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

China National Accord Medicines Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Other Long-Term Liabilities Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

China National Accord Medicines Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.


China National Accord Medicines Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of China National Accord Medicines's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


China National Accord Medicines (SZSE:000028) Business Description

Traded in Other Exchanges
Address
No. 15, Ba Gua Si 4th Road, Accord Pharmaceutical Building, Futian District, Guangdong Province, Shenzhen, CHN, 518029
China National Accord Medicines Corp Ltd develops and manufactures pharmaceuticals in China. The company engaged in the wholesale of Chinese patent drugs, traditional Chinese medicines, chemical medicine preparations, antibiotics, biochemical drugs and cerebrovascular system drugs. It operates through the following segments: The Head office segment engages in investing and managing the business; The Pharmaceutical Distribution segment engages in the distribution of medicine and pharmaceutical products to customers, including hospitals, other distributors, retail drug stores, and clinics, and Retail pharmacy segment, which is managing the operation of Guoda Pharmacy. It generates maximum revenue from the Pharmaceutical Distribution segment.

China National Accord Medicines (SZSE:000028) Headlines

No Headlines